Healthcare & Life Sciences, Eversheds Sutherland (International) LLP updates

European Union

Contributed by Eversheds Sutherland (International) LLP
European Union recommends measures to be taken for use of technology and data to combat COVID-19
  • European Union
  • 23 December 2020

In April 2020 the European Commission issued Recommendation 2020/518 on establishing a common EU toolbox for the use of technology and data to combat the COVID-19 crisis, particularly with regard to mobile apps and the use of anonymised mobility data. The recommendation sets out a process to develop a common approach – a so-called 'toolbox' – in the European Union using the most innovative digital means to address the health crisis.

European Union issues communication on COVID-19 vaccination strategy
  • European Union
  • 09 December 2020

According to the European Commission, the swift development and global deployment of safe and effective vaccines against COVID-19 is key to resolving the current public health crisis. In this context, the European Commission is working to ensure Europe-wide access to safe vaccines and encouraging a coordinated vaccination strategy. Thus, in June 2020 the European Union published a communication on the EU Strategy for COVID-19 vaccines, which sets out a number of strategic objectives.

Short-term health preparedness for COVID-19 outbreaks
  • European Union
  • 25 November 2020

The European Union recently published a communication on the European Union's short-term health preparedness for COVID-19 outbreaks, which aims to reinforce the European Union's preparedness and create a coordinated response capacity to counter further outbreaks of COVID-19. This article highlights the main measures provided by the communication, including with regard to testing, contact tracing and medical countermeasures.

Latest EU measures relating to COVID-19 pandemic – multicentre clinical trials
  • European Union
  • 11 November 2020

Since COVID-19 began to spread, the majority of the world's leading pharmaceutical laboratories have begun clinical trials to find both the right vaccine and the right drug to stop it from spreading. Against this background, EU Regulation 2020/1043 aims to grant a temporary derogation from the requirements concerning a prior environmental risk assessment for the duration of the COVID-19 pandemic or as long as there is a public health emergency.

Cybersecurity in healthcare sector – Q&A on data breaches in relation to medical devices
  • European Union
  • 19 August 2020

The use of connected medical devices has changed the way in which the healthcare sector works. However, the various benefits based on the advance of connected healthcare come with an increased flow of personal data, whether in hospitals or between different market players in the healthcare industry, which has led to an increased risk of cybersecurity incidents and personal data breaches.

Current search